chenodeoxycholic acid has been researched along with Liver Dysfunction in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 46 (51.69) | 18.7374 |
1990's | 15 (16.85) | 18.2507 |
2000's | 6 (6.74) | 29.6817 |
2010's | 17 (19.10) | 24.3611 |
2020's | 5 (5.62) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Deng, R; Fang, W; Huan, Y; Jiang, Q; Liu, J; Liu, S; Shen, Z; Sun, D; Tan, W; Verma, R; Wang, N; Wang, X; Wong, C; Xu, Y; Zhang, G; Zhang, Y | 1 |
Ravindranath, A; Sen Sarma, M; Yachha, SK | 1 |
Bedossa, P; Bowlus, CL; Drenth, JPH; Forman, LM; Iloeje, U; Jin, Y; Kremer, AE; Liberman, A; MacConell, L; Parés, A; Pencek, R; Pockros, PJ; Ryder, SD; Terracciano, L | 1 |
Baldoni, M; Biagioli, M; Bordoni, M; Carino, A; Di Giorgio, C; Distrutti, E; Fiorucci, C; Fiorucci, S; Marchianò, S; Monti, MC; Morretta, E; Ricci, P; Roselli, R; Zampella, A | 1 |
Guan, L; Miao, P | 1 |
Gong, JY; Setchell, KDR; Tang, YP; Wang, JS; Zhang, W; Zhao, J | 1 |
Beuers, U; Hohenester, S | 1 |
Adorini, L; Berardo, C; Di Pasqua, LG; Ferrigno, A; Richelmi, P; Rizzo, V; Siciliano, V; Vairetti, M | 1 |
Blomenkamp, K; Greenspon, J; Guzman, MA; Heafner, N; Kakarla, V; Korremla, N; Kumar Jain, A; Manithody, C; Phillips, W; Pochampally, S; Price, A; Ratchford, T; Saxena, S; Villalona, G; Westrich, M | 1 |
Hao, H; He, Q; Wang, G; Wang, H; Xu, X | 1 |
Rockey, DC | 1 |
Gege, C; Hambruch, E; Hambruch, N; Kinzel, O; Kremoser, C | 1 |
Di Giorgio, C; Distrutti, E; Fiorucci, S | 1 |
Al-Dury, S; Bäckhed, F; Fändriks, L; Fickert, P; Marschall, HU; Panzitt, K; Ståhlman, M; Thorell, A; Trauner, M; Wagner, M; Wahlström, A | 1 |
Clayton, PT; Coupry, I; Crick, PJ; Dai, D; Footitt, E; Gissen, P; Goizet, C; Griffiths, WJ; Kimura, A; Lavie, J; McClean, P; Mills, PB; Mizuochi, T; Mochel, F; Nittono, H; Schwarz, K; Stahlschmidt, J; Wang, Y | 1 |
Cohen, H; Hartman, C; Iancu, TC; Lev, MR; Rinawi, F; Shamir, R; Yarden-Bilavsky, H | 1 |
Asgharpour, A; Kumar, D; Sanyal, A | 1 |
Alawad, AS; Levy, C | 1 |
Li, B; Ma, X; Wang, QX | 1 |
Alaggio, R; D'Antiga, L; Giordano, G; Guido, M; Riello, L; Zancan, L | 1 |
Baldelli, F; Bifulco, G; Cipriani, S; Fiorucci, S; Mencarelli, A; Zampella, A | 1 |
Burrin, DG; Holst, JJ; Jain, AK; Moore, DD; Stoll, B | 1 |
Hugosson, C; Khorsheed, SS; Nazer, H | 1 |
Aratsu, Z; Bouscarel, B; Ceryak, S; Epstein, L; Jones, L; Meng, JP | 1 |
Alvarez, AR; Amigo, L; Ferrada, C; Galdames, L; Klein, A; Miquel, JF; Morales, MG; Quinones, V; Rigotti, A; Rio, MC; Tichauer, JE; Zanlungo, S | 1 |
Fukunari, A; Imada, T; Ishizaki, K; Iwaki, T; Kinoshita, S; Tanaka, H; Tsurufuji, M | 1 |
Matsui, A; Setchell, KD | 1 |
de Jager, AE; Gips, CH; Koopman, BJ; van der Molen, JC; Waterreus, RJ; Wolthers, BG | 1 |
Nemeth, A; Samuelson, K; Strandvik, B | 1 |
Buffet, C; Chaput, JC; Etienne, JP; Franco, D; Houssin, D; Labayle, D | 1 |
Bull, HJ; Coltart, DJ; Gilmore, IT; Marigold, JH; Thompson, RP | 1 |
Baker, D; Gochman, N; Javitt, NB; Jones, HM; Miyai, K | 1 |
Balistreri, WF; Farrell, MK; Heubi, JE; Suchy, FJ | 1 |
Beckett, GJ; Douglas, JG; Finlayson, ND; Percy-Robb, IW | 1 |
Aly, A; Johansson, C; Norman, A; Samuelson, K | 1 |
Fehér, T; Loi, HG; Magyar, I | 1 |
Eklund, A; Samuelson, K | 1 |
Fujiwara, K; Matsui, A; Nagoshi, S; Ohta, Y | 1 |
Hotta, H; Makino, I; Nakamura, K | 1 |
Alonso, JR; Badia, MD; el-Mir, MY; Marin, JJ; Monte, MJ; Palomero, F | 1 |
Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H | 1 |
Azer, SA; Byth, K; Coverdale, SA; Farrell, GC; Stacey, NH | 1 |
Crosignani, A; Invernizzi, P; Larghi, A; Podda, M; Rodrigues, CM; Setchell, KD | 1 |
Bateson, MC | 1 |
Fujisawa, T; Hoshiyama, A; Inoue, T; Kato, H; Kimura, A; Kurosawa, T; Murai, T; Nakashima, E; Sata, M; Suzuki, M; Tohma, M; Yamashita, Y | 1 |
Kase, BF; Sletta, RJ; Solaas, K; Søreide, O | 1 |
Aldini, R; Azzaroli, F; Montagnani, M; Piazza, F; Roda, A; Roda, E; Russo, C | 1 |
Chen, T; Dyrszka, H; Mosbach, EH; Salen, G; Saltzman, WH | 1 |
Faust, H; Gyr, K | 1 |
Cochrane, AM; Ellis, WR; Hughes, RD; Murray-Lyon, IM; Williams, R | 1 |
Hofmann, AF | 1 |
Dowling, RH | 1 |
Gregory, DH; Prugh, MF; Swell, L; Vlahcevic, ZR | 1 |
Bereziat, G; Pepin, D; Polonovski, J; Wolf, C | 1 |
Tangedahl, T | 1 |
Schmack, B | 1 |
Baqir, YA; Bouchier, IA; Murison, J; Ross, PE | 1 |
Baqir, YA; Bouchier, IA; Murison, J; Pennington, CR; Ross, PE | 1 |
Bouchier, IA; Pennington, CR; Ross, PE | 1 |
Bateson, MC; Bouchier, IA; Pennington, CR; Ross, PE | 1 |
Paraf, A | 1 |
Kutz, K; Miederer, SE; Paumgartner, G | 1 |
Fujimoto, T; Higuchi, M; Matsuoka, Y; Matsuyama, Y; Morita, T; Tsujii, T | 1 |
Chadwick, VS; Clark, ML; Fairclough, PD; Feest, TG | 1 |
Aldini, R; Barbara, L; Festi, D; Mazzella, G; Roda, A; Roda, E; Sama, C | 1 |
Angelico, M; Attili, AF; Capocaccia, L | 1 |
Hanson, RF; Isenberg, JN; Page, AR; Sharp, HL; Williams, GC; Zavoral, J | 1 |
Demers, LM; Hepner, GW | 1 |
Hashimoto, H; Makino, I; Nakagawa, S; Shinozaki, K; Yoshino, K | 1 |
Czygan, P; Kommerell, B; Stiehl, A | 1 |
Guma, C; Viola, L | 1 |
Egestad, B; Marschall, HU; Matern, H; Matern, S; Sjövall, J; Wietholtz, H | 1 |
Berenson, MM; Garcia-Marin, JJ; Welch, V | 1 |
Axelson, M; Sjövall, J | 1 |
Clayton, P; Gunasekaran, T; Ichimiya, H; Nazer, H; Sjövall, J | 1 |
Baart de la Faille, H; Cleton, MI; Kooijman, C; Rademakers, LH; van Hattum, J | 1 |
Berenson, MM; Bjorkman, DJ; Gunther, C; Samowitz, WS | 1 |
Matsuoka, M; Okumura, M | 1 |
Baart de la Faille, H; Edixhoven-Bosdijk, A; Van den Berg, JW; Van Hattum, J; Wilson, JH | 1 |
Heymans, HS; Schutgens, RB; Wanders, RJ | 1 |
De la Pierre, M; Ferraris, R; Fiorentini, MT; Galatola, G; Rolfo, P | 1 |
Kallner, A; Rosing, U | 1 |
Björkhem, I; Kase, BF; Pedersen, JI; Strandvik, B | 1 |
Banwell, JG; Lockwood, DH; Nair, PP; Sherr, HP; White, JJ | 1 |
Kuroda, T; Okuda, K | 1 |
Murphy, GM; Signer, E | 1 |
Makino, I; Mashimo, K; Nakagawa, S; Shinozaki, K | 1 |
Bell, CC; McCormick, WC; Swell, L; Vlahcevic, ZR | 1 |
Erb, W; Schreiber, J; Walczak, M | 1 |
15 review(s) available for chenodeoxycholic acid and Liver Dysfunction
Article | Year |
---|---|
Systematic review and meta-analysis of randomized controlled trials on the effects of obeticholic acid on the blood lipid profile: Insights into liver disorders and liver cancer.
Topics: Chenodeoxycholic Acid; Humans; Lipids; Lipoproteins; Liver Diseases; Liver Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
[Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].
Topics: Adult; Bezafibrate; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Humans; Liver Diseases; Ursodeoxycholic Acid | 2017 |
FXR modulators for enterohepatic and metabolic diseases.
Topics: Animals; Chenodeoxycholic Acid; Drug Design; Humans; Ligands; Liver Diseases; Metabolic Diseases; Patents as Topic; Receptors, Cytoplasmic and Nuclear | 2018 |
Nonsteroidal FXR Ligands: Current Status and Clinical Applications.
Topics: Chenodeoxycholic Acid; Humans; Ligands; Liver Diseases; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear | 2019 |
Obeticholic Acid: An Update of Its Pharmacological Activities in Liver Disorders.
Topics: Chenodeoxycholic Acid; Humans; Liver Diseases; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled | 2019 |
Bile acids: emerging role in management of liver diseases.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Gastrointestinal Agents; Humans; Liver Diseases; Receptors, G-Protein-Coupled | 2015 |
FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
Topics: Animals; Azepines; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Indoles; Isoxazoles; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2016 |
[Research advances in autoimmune liver diseases in 2016].
Topics: Autoimmune Diseases; Biomedical Research; Chenodeoxycholic Acid; Cholangitis; Cholangitis, Sclerosing; Clinical Trials, Phase III as Topic; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Diseases | 2017 |
Serum bile acid analysis.
Topics: Adult; Aged; Bile Acids and Salts; Bile Ducts; Chenodeoxycholic Acid; Child; Child, Preschool; Cholic Acids; Chromatography, Gas; Chromatography, Gel; Deoxycholic Acid; Female; Gas Chromatography-Mass Spectrometry; Humans; Ileum; Lithocholic Acid; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged | 1983 |
Clinical pharmacokinetics of therapeutic bile acids.
Topics: Absorption; Administration, Oral; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Chronic Disease; Humans; Injections, Intravenous; Liver; Liver Diseases; Ursodeoxycholic Acid | 1996 |
[Bile acids in clinical medicine: what is new, and what has practical significance?].
Topics: Bile Acids and Salts; Blind Loop Syndrome; Chenodeoxycholic Acid; Cholelithiasis; Diarrhea; Humans; Ileum; Intestine, Small; Liver Diseases; Liver Function Tests; Oxalates; Oxygen Consumption | 1977 |
Chenodeoxycholic acid therapy of gallstones.
Topics: Bile; Biopsy; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Diarrhea; Humans; Liver; Liver Diseases; Recurrence | 1977 |
Disturbances of bile acid metabolism in parenchymal liver cell disease.
Topics: Acute Disease; Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholic Acids; Chronic Disease; Enterohepatic Circulation; Hepatitis; Humans; Infant, Newborn; Jaundice, Neonatal; Liver; Liver Cirrhosis; Liver Diseases; Phototherapy | 1977 |
Dissolution of gallstones--when and how?
Topics: Bile; Chenodeoxycholic Acid; Cholecystography; Cholelithiasis; Drug Administration Schedule; Female; Humans; Liver Diseases; Obesity; Pregnancy; Ursodeoxycholic Acid | 1979 |
Bile acid metabolism in infants and children.
Topics: Bile; Bile Acids and Salts; Biological Transport, Active; Chenodeoxycholic Acid; Child; Child, Preschool; Cholestasis; Cholesterol; Cholic Acids; Deoxycholic Acid; Humans; Infant; Infant Nutrition Disorders; Infant, Newborn; Lithocholic Acid; Liver; Liver Diseases; Malabsorption Syndromes; Surface Properties | 1974 |
4 trial(s) available for chenodeoxycholic acid and Liver Dysfunction
Article | Year |
---|---|
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis.
Topics: Chenodeoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 2020 |
Obeticholic acid may increase the risk of gallstone formation in susceptible patients.
Topics: Adult; Bile Acids and Salts; Biopsy; Carrier Proteins; Chenodeoxycholic Acid; Cholestenones; Double-Blind Method; Female; Fibroblast Growth Factors; Gallbladder; Gallstones; Gene Expression; Humans; Liver; Liver Diseases; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear; Treatment Outcome | 2019 |
Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease.
Topics: Adult; Aged; Bile Acids and Salts; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Cholestasis; Cholic Acid; Cholic Acids; Chromatography, High Pressure Liquid; Chronic Disease; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Rate | 1996 |
Diagnostic value of serum immunoreactive conjugated cholic or chenodeoxycholic acids in detecting hepatobiliary diseases. Comparison with levels of 3 alpha-hydroxy bile acids determined enzymatically and with routine liver tests.
Topics: Adolescent; Adult; Bile Acids and Salts; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Female; Fluorometry; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Radioimmunoassay; Random Allocation | 1987 |
70 other study(ies) available for chenodeoxycholic acid and Liver Dysfunction
Article | Year |
---|---|
Synthesis and biological evaluations of chalcones, flavones and chromenes as farnesoid x receptor (FXR) antagonists.
Topics: Animals; Benzopyrans; Chalcones; Flavones; Liver; Liver Diseases; Mice; Receptors, Cytoplasmic and Nuclear; Triglycerides | 2017 |
Bile acid synthetic defects: Simplified approach in a nutshell.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol; Cholic Acid; Enzymes; Humans; Liver Diseases; Metabolism, Inborn Errors | 2020 |
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis.
Topics: Animals; Chenodeoxycholic Acid; Cholestasis; Hep G2 Cells; Humans; Liver; Liver Diseases; MafG Transcription Factor; Male; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Rats, Wistar; Receptors, Cytoplasmic and Nuclear | 2020 |
Successful treatment of infantile oxysterol 7α-hydroxylase deficiency with oral chenodeoxycholic acid.
Topics: Adolescent; Bile Acids and Salts; Chenodeoxycholic Acid; Female; Humans; Infant; Liver Diseases; Liver Transplantation; Male; Oxysterols | 2021 |
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.
Topics: Animals; Antiporters; Arginine; Biliary Tract; Blotting, Western; Carrier Proteins; Chenodeoxycholic Acid; Liver Diseases; Male; Nitric Oxide Synthase; Organic Cation Transport Proteins; Protein-Arginine N-Methyltransferases; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Reperfusion Injury; RNA, Messenger; Up-Regulation | 2018 |
No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Disease Models, Animal; Fibroblast Growth Factors; Gastrointestinal Tract; Intestine, Small; Liver; Liver Diseases; Parenteral Nutrition; Parenteral Nutrition, Total; Polymerase Chain Reaction; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Cytoplasmic and Nuclear; Short Bowel Syndrome; Swine | 2018 |
Editorial: Advances in Hepatology: 2019.
Topics: Antiviral Agents; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; End Stage Liver Disease; Gastroenterology; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Non-alcoholic Fatty Liver Disease; Palliative Care | 2019 |
Liver disease in infancy caused by oxysterol 7 α-hydroxylase deficiency: successful treatment with chenodeoxycholic acid.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Consanguinity; Cytochrome P450 Family 7; Humans; Infant; Liver; Liver Diseases; Male; Metabolism, Inborn Errors; Steroid Hydroxylases | 2014 |
Fat malabsorption due to bile acid synthesis defect.
Topics: 3-Hydroxysteroid Dehydrogenases; Chenodeoxycholic Acid; Child, Preschool; Dietary Fats; Failure to Thrive; Gastrointestinal Agents; Humans; Liver Diseases; Malabsorption Syndromes; Male; Mutation; Treatment Outcome | 2015 |
Titration of bile acid supplements in 3beta-hydroxy-Delta 5-C27-steroid dehydrogenase/isomerase deficiency.
Topics: 3-Hydroxysteroid Dehydrogenases; Biopsy; Chenodeoxycholic Acid; Child; Child, Preschool; Cholagogues and Choleretics; Cholic Acids; Chromatography, Liquid; Dietary Supplements; Disease Progression; Humans; Infant; Infant, Newborn; Isomerases; Liver Diseases; Steroid Metabolism, Inborn Errors; Tandem Mass Spectrometry; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA.
Topics: Animals; Chenodeoxycholic Acid; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Hypoglycemic Agents; Liver Diseases; Metabolic Diseases; Receptors, Cytoplasmic and Nuclear | 2011 |
Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs.
Topics: Animals; Animals, Newborn; Atrophy; Chenodeoxycholic Acid; Cholestasis; Disease Models, Animal; Fibroblast Growth Factors; Glucagon-Like Peptides; Intestinal Mucosa; Liver Diseases; Parenteral Nutrition, Total; Swine; Treatment Outcome | 2012 |
Regression of diaphyseal multiloculated bone cyst in familial steroid dehydrogenase deficiency.
Topics: 3-Hydroxysteroid Dehydrogenases; Bilirubin; Bone Cysts; Chenodeoxycholic Acid; Cholestasis; Hepatomegaly; Humans; Infant; Liver Diseases; Male; Splenomegaly | 2003 |
Biphasic regulation by bile acids of dermal fibroblast proliferation through regulation of cAMP production and COX-2 expression level.
Topics: Alprostadil; Bile Acids and Salts; Cell Proliferation; Chenodeoxycholic Acid; Colforsin; Cyclic AMP; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Fibroblasts; Forearm; Humans; Liver Diseases; Membrane Proteins; RNA, Messenger; Skin | 2006 |
Overexpression of the cholesterol-binding protein MLN64 induces liver damage in the mouse.
Topics: Adenoviridae; Alkaline Phosphatase; Animals; Apoptosis; Cell Line; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; CHO Cells; Cholesterol; Cricetinae; Cricetulus; Disease Models, Animal; Gene Expression Regulation; Humans; Liver; Liver Diseases; Mice; Mice, Inbred C57BL; Phenotype; Phosphoproteins; Transfection | 2007 |
Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
Topics: Alanine Transaminase; Animals; Bile Acids and Salts; Body Weight; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cricetinae; Eating; Liver; Liver Diseases; Mesocricetus; Ursodeoxycholic Acid | 2007 |
Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis).
Topics: Brain Diseases, Metabolic; Chenodeoxycholic Acid; Cholestanol; Cholesterol; Chromatography, Gas; Gas Chromatography-Mass Spectrometry; Humans; Liver Diseases; Xanthomatosis | 1984 |
Serum bile acids as markers of juvenile liver disease in alpha 1-antitrypsin deficiency.
Topics: Adolescent; Adult; alpha 1-Antitrypsin Deficiency; Bile Acids and Salts; Chenodeoxycholic Acid; Child; Child, Preschool; Cholic Acids; Humans; Infant; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Phenotype; Radioimmunoassay | 1982 |
[Hepatology in 1981].
Topics: Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholelithiasis; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Liver Transplantation; Peliosis Hepatis; Peritoneovenous Shunt; Ursodeoxycholic Acid | 1981 |
Direct measurement of hepatic extraction of chenodeoxycholic acid and ursodeoxycholic acid in man.
Topics: Adult; Aged; Chenodeoxycholic Acid; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1982 |
Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid.
Topics: Animals; Bile Canaliculi; Body Weight; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cytoskeleton; Deoxycholic Acid; Lithocholic Acid; Liver; Liver Diseases; Prognosis; Rabbits; Ursodeoxycholic Acid | 1982 |
Pathologic versus physiologic cholestasis: elevated serum concentration of a secondary bile acid in the presence of hepatobiliary disease.
Topics: Biliary Tract Diseases; Chenodeoxycholic Acid; Cholestasis; Cholic Acids; Humans; Infant; Infant, Newborn; Lithocholic Acid; Liver Diseases; Sulfates | 1981 |
Differential timing of maximal postprandial concentrations of plasma chenodeoxycholate and cholate: its variability and implications.
Topics: Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Female; Food; Humans; Liver Diseases; Male; Time Factors | 1981 |
Evaluation of fasting serum bile acid concentration in patients with liver and gastrointestinal disorders.
Topics: Bile Acids and Salts; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholic Acids; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Diseases; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests | 1981 |
Plasma bile acid levels and liver disease.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Cholic Acids; Deoxycholic Acid; Diagnosis, Differential; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Spectrometry, Fluorescence | 1981 |
Determination of urinary cholic and chenodeoxycholic acid conjugates with radioimmunoassay.
Topics: Adult; Chenodeoxycholic Acid; Cholic Acids; Chromatography, Gas; Female; Humans; Liver Diseases; Male; Middle Aged; Radioimmunoassay; Reference Values | 1980 |
Protective action of putrescine against rat liver injury.
Topics: Administration, Oral; Animals; Carbon Tetrachloride Poisoning; Cell Membrane; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Galactosamine; Lipid Peroxidation; Liver; Liver Diseases; Male; Octoxynol; Peroxides; Putrescine; Rats; Rats, Sprague-Dawley; tert-Butylhydroperoxide | 1994 |
[Clinical significance of 3 beta, 7 beta-dihydroxy-5 beta-cholan-24-oic acid (isoUDCA) in serum during administration of ursodeoxycholic acid].
Topics: Chenodeoxycholic Acid; Humans; Liver Diseases; Ursodeoxycholic Acid | 1993 |
Effects of selective zonal injury on bile acid-induced bile flow in the isolated rat liver.
Topics: Animals; Bile; Bile Acids and Salts; Biotransformation; Chenodeoxycholic Acid; Cholagogues and Choleretics; In Vitro Techniques; Liver; Liver Diseases; Male; Rats; Rats, Wistar; Taurocholic Acid; Ursodeoxycholic Acid | 1993 |
Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
Topics: Adult; Aged; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chronic Disease; Deoxycholic Acid; Dinoprostone; Female; Hepatitis C; Humans; Indomethacin; Killer Cells, Natural; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1996 |
Bile acid research and applications.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholestasis, Intrahepatic; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Pregnancy; Pregnancy Complications; Research; Ursodeoxycholic Acid | 1997 |
Urinary 7alpha-hydroxy-3-oxochol-4-en-24-oic and 3-oxochola-4,6-dien-24-oic acids in infants with cholestasis.
Topics: Adolescent; Adult; Aged; Biliary Atresia; Case-Control Studies; Chenodeoxycholic Acid; Child; Child, Preschool; Cholestasis; Female; Gas Chromatography-Mass Spectrometry; Humans; Infant; Liver Diseases; Male; Middle Aged; Oxidoreductases | 1998 |
Presence of choloyl- and chenodeoxycholoyl-coenzyme A thioesterase activity in human liver.
Topics: Acyltransferases; Bacterial Proteins; Bile Acids and Salts; Carbon Radioisotopes; Chenodeoxycholic Acid; Cholic Acid; Cysts; Dinitrobenzenes; Enzyme Activation; Humans; Liver; Liver Diseases; Peroxisomes; Protein Binding; Subcellular Fractions; Thiolester Hydrolases | 2000 |
Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
Topics: Alkaline Phosphatase; Animals; Bile Acids and Salts; Carrier Proteins; Chenodeoxycholic Acid; Humans; Hydroxysteroid Dehydrogenases; L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2000 |
Letter Prevention of chenodeoxycholic-acid toxicity with lincomycin.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholelithiasis; Drug Antagonism; Lincomycin; Liver; Liver Diseases; Macaca mulatta | 1975 |
[New therapeutic possibilities in the diagnosis of congenital cystic bile duct dilatations (author's transl)].
Topics: Bile Ducts; Biliary Dyskinesia; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholangiography; Cholangitis; Cysts; Diagnosis, Differential; Dilatation, Pathologic; Drainage; Female; Humans; Liver Cirrhosis; Liver Diseases; Syndrome | 1977 |
Studies on plasma cytotoxicity and liver regeneration in fulminant hepatic failure.
Topics: Ammonia; Animals; Chenodeoxycholic Acid; Cytotoxins; Dialysis; Hemoperfusion; Hepatic Encephalopathy; Hot Temperature; Humans; Lithocholic Acid; Liver; Liver Diseases; Liver Regeneration; Rabbits | 1977 |
[Plasma bile acids fractionnation by gas-liquid chromatography : application to hepatocellular deficiency investigation (author's transl)].
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acids; Chromatography, Gas; Deoxycholic Acid; Hepatitis, Viral, Human; Humans; Lithocholic Acid; Liver Cirrhosis; Liver Diseases | 1977 |
[Clinical significance of bile acids].
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Colonic Neoplasms; Deoxycholic Acid; Gastritis; Humans; Intestinal Absorption; Liver Diseases; Oxalates; Stomach Ulcer | 1979 |
Radioimmunoassay of primary bile salts in serum.
Topics: Adult; Animals; Antibody Specificity; Bile Acids and Salts; Cattle; Chenodeoxycholic Acid; Cholic Acids; Humans; Liver Diseases; Rabbits; Radioimmunoassay | 1979 |
Measurement of serum primary bile acid ratio by gas liquid chromatography and radioimmunoassay.
Topics: Animals; Bile Acids and Salts; Cattle; Chenodeoxycholic Acid; Cholic Acids; Chromatography, Gas; Humans; Liver Diseases; Rabbits; Radioimmunoassay | 1979 |
Serum bile acids in the diagnosis of hepatobiliary disease.
Topics: Bile Acids and Salts; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; Humans; Liver Diseases; Liver Function Tests | 1977 |
Serum bile acids in patients with hyperlipidaemia.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; Humans; Hyperlipidemias; Liver Diseases | 1978 |
[The liver and migraine].
Topics: Chenodeoxycholic Acid; Humans; Liver Diseases; Migraine Disorders | 1978 |
Case report: chenodeoxycholic acid therapy of intrahepatic radiolucent gallstones in a patient with Caroli's syndrome.
Topics: Adult; Bile Ducts, Intrahepatic; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholangiography; Cholelithiasis; Dilatation, Pathologic; Humans; Liver Diseases; Male; Syndrome | 1978 |
Clinical significance of serum bile acid measurement in liver diseases.
Topics: Acute Disease; Adult; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Cholic Acids; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Diseases | 1978 |
Effect of sodium chenodeoxycholate on oxalate absorption from the excluded human colon--a mechanism for 'enteric' hyperoxaluria.
Topics: Adult; Aged; Chenodeoxycholic Acid; Chronic Disease; Colon; Humans; Intestinal Absorption; Liver Diseases; Oxalates; Perfusion; Time Factors; Water | 1977 |
Development, validation, and application of a single-tube radioimmunoassay for cholic and chenodeoxycholic conjugated bile acids in human serum.
Topics: Carbon Radioisotopes; Chenodeoxycholic Acid; Cholic Acids; Cross Reactions; Dose-Response Relationship, Drug; Glycochenodeoxycholic Acid; Glycocholic Acid; Humans; Isotope Labeling; Liver Diseases; Microchemistry; Radioimmunoassay; Tritium | 1977 |
Fasting and postprandial serum bile acids as a screening test for hepatocellular disease.
Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acids; Chromatography, Gas; Eating; Fasting; Female; Hepatitis; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Time Factors | 1977 |
Immunodeficiency, xanthomas and obstructive liver disease.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Child; Cholestyramine Resin; Cholic Acids; Humans; Hypercholesterolemia; Hyperlipidemias; Immunologic Deficiency Syndromes; Liver Diseases; Male; Phenobarbital; Pruritus; Xanthomatosis | 1976 |
Levels of immunoreactive glycine-conjugated bile acids in health and hepatobiliary disease.
Topics: Alcoholism; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholestasis; Cholic Acids; Deoxycholic Acid; Glycocholic Acid; Hepatitis; Humans; Lithocholic Acid; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Radioimmunoassay | 1976 |
Sulfated and nonsulfated bile acids in urine, serum, and bile of patients with hepatobiliary diseases.
Topics: Bile Acids and Salts; Biliary Tract Diseases; Carbon Radioisotopes; Chenodeoxycholic Acid; Cholestasis; Cholic Acids; Chromatography, Gas; Deoxycholic Acid; Female; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Male; Sulfates | 1975 |
[Treatment of hepato-choledocholithiasis with chenodeoxycholic acid in intrahepatic bile-duct cysts (M. Caroli)].
Topics: Adult; Chenodeoxycholic Acid; Cholelithiasis; Cysts; Hepatic Duct, Common; Humans; Liver Diseases; Male | 1975 |
[Ursotherapy in hepatobiliary diseases].
Topics: Chenodeoxycholic Acid; Cholelithiasis; Cholestasis; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |
Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
Topics: Acetylglucosamine; Administration, Oral; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Deoxycholic Acid; Glycosides; Humans; Hydroxylation; Liver Diseases; Mass Spectrometry; Ursodeoxycholic Acid | 1992 |
Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
Topics: Absorption; Animals; Bile; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholestasis, Intrahepatic; Cholic Acid; Cholic Acids; Female; Griseofulvin; Liver; Liver Diseases; Mice; Protoporphyrins; Structure-Activity Relationship; Ursodeoxycholic Acid | 1991 |
Potential bile acid precursors in plasma--possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in man.
Topics: Adult; Aged; Chenodeoxycholic Acid; Cholestenes; Cholestenones; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Cholic Acids; Female; Health Status; Humans; Intestinal Absorption; Liver Diseases; Male; Middle Aged; Models, Biological | 1990 |
Treatment of chronic liver disease caused by 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency with chenodeoxycholic acid.
Topics: 3-Hydroxysteroid Dehydrogenases; Administration, Oral; Chenodeoxycholic Acid; Child, Preschool; Chronic Disease; Growth Disorders; Humans; Liver Diseases; Male; Pruritus | 1990 |
Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment.
Topics: Adolescent; Adult; Bile Canaliculi; Biopsy, Needle; Chenodeoxycholic Acid; Child; Female; Humans; Liver; Liver Diseases; Male; Microscopy, Electron; Middle Aged; Porphyrias; Porphyrins; Protoporphyrins | 1990 |
Formation of biliary thrombi in protoporphyrin-induced cholestasis in perfused rat liver.
Topics: Animals; Bile; Bile Acids and Salts; Biliary Tract Diseases; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cholestasis; In Vitro Techniques; L-Lactate Dehydrogenase; Liver; Liver Diseases; Microscopy, Electron; Perfusion; Porphyrins; Protoporphyrins; Rats; Rats, Inbred Strains; Taurocholic Acid; Ursodeoxycholic Acid | 1990 |
Radioimmunoassay of chenodeoxycholic acid-3-sulfate in urine.
Topics: Binding, Competitive; Chenodeoxycholic Acid; Chromatography, Gas; Humans; Liver Diseases; Radioimmunoassay | 1988 |
Chenodeoxycholic acid therapy in erythrohepatic protoporphyria.
Topics: Chenodeoxycholic Acid; Erythrocytes; Humans; Liver; Liver Diseases; Porphyrias; Porphyrins; Protoporphyrins; Time Factors | 1986 |
Deficient cholesterol side chain oxidation in patients without peroxisomes (Zellweger syndrome): evidence for the involvement of peroxisomes in bile acid synthesis in man.
Topics: Bile Acids and Salts; Brain Diseases; Chenodeoxycholic Acid; Cholesterol; Cholic Acid; Cholic Acids; Humans; Kidney Diseases; Liver; Liver Diseases; Microbodies; Oxidation-Reduction; Protein Processing, Post-Translational; Syndrome | 1987 |
Serum cholic and chenodeoxycholic acids during pregnancy and puerperium in normal and pre-eclamptic women.
Topics: Chenodeoxycholic Acid; Cholic Acids; Female; Humans; Liver; Liver Diseases; Postpartum Period; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Puerperal Disorders | 1986 |
In vivo and vitro studies on formation of bile acids in patients with Zellweger syndrome. Evidence that peroxisomes are of importance in the normal biosynthesis of both cholic and chenodeoxycholic acid.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholestenones; Cholic Acid; Cholic Acids; Humans; Kinetics; Liver Diseases; Metabolic Clearance Rate; Microbodies; Subcellular Fractions; Syndrome | 1985 |
Bile acid metabolism and hepatic disease following small bowel bypass for obesity.
Topics: Adult; Bile; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; Fatty Liver; Female; Glycine; Humans; Ileum; Jejunum; Lithocholic Acid; Liver; Liver Cirrhosis; Liver Diseases; Male; Obesity; Postoperative Complications; Protein Deficiency; Sulfuric Acids; Taurine | 1974 |
Bile acids in hepatic bile in liver disease.
Topics: Acute Disease; Adolescent; Adult; Bile; Bile Acids and Salts; Biliary Fistula; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; Glycocholic Acid; Hepatitis A; Humans; Liver; Liver Cirrhosis; Liver Diseases; Middle Aged; Taurocholic Acid | 1974 |
Sulfated and nonsulfated bile acid in human serum.
Topics: Adult; Aged; Bile Acids and Salts; Biliary Tract Diseases; Chenodeoxycholic Acid; Cholestasis; Cholic Acids; Chromatography, Gel; Chromatography, Ion Exchange; Deoxycholic Acid; Female; Glycocholic Acid; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Sulfuric Acids; Taurocholic Acid | 1972 |
Cholic acid synthesis as an index of the severity of liver disease in man.
Topics: Adult; Aged; Ascites; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; Hepatic Encephalopathy; Humans; Kinetics; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Varicose Veins | 1973 |
[Bile acids in the serum of patients with extrahepatic cholestasis with chronic liver diseases].
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholestasis; Cholic Acids; Chronic Disease; Deoxycholic Acid; Hepatic Encephalopathy; Hepatitis; Humans; Lithocholic Acid; Liver Cirrhosis; Liver Diseases | 1973 |